+Compare
POAI
Stock ticker:
NASDAQ
AS OF
Jun 27 closing price
Price
$0.44
Change
+$0.02 (+4.76%)
Capitalization
33.12M

POAI Predictive Oncology Forecast, Technical & Fundamental Analysis

a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jun 24, 2022

POAI in downward trend: price expected to drop as it breaks its higher Bollinger Band on June 03, 2022

POAI broke above its upper Bollinger Band on June 03, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In 34 of the 37 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 17, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on POAI as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for POAI entered a downward trend on May 19, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where POAI's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where POAI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for POAI just turned positive on June 01, 2022. Looking at past instances where POAI's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where POAI advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.891) is normal, around the industry mean (7.126). P/E Ratio (0.000) is within average values for comparable stocks, (91.157). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (18.116) is also within normal values, averaging (90.334).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. POAI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI

View a ticker or compare two or three

AI
A.I. Advisor
published Earnings

POAI is expected to report earnings to fall 40.00% to -2 cents per share on August 17

Predictive Oncology POAI Stock Earnings Reports
Q2'22
Est.
$-0.03
Q1'22
Missed
by $0.01
Q4'21
Missed
by $0.10
Q3'21
Missed
by $0.03
Q2'21
Beat
by $0.03
The last earnings report on May 12 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 251.08K shares outstanding, the current market capitalization sits at 33.12M.
AI
A.I. Advisor
published General Information

General Information

a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2915 Commers Drive
Phone
+1 651 389-4800
Employees
32
Web
https://www.predictive-oncology.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGI12.841.00
+8.45%
Triumph Group
CNHI12.020.64
+5.62%
CNH Industrial NV
FIX83.023.72
+4.69%
Comfort Systems USA
HEAR13.920.30
+2.20%
Turtle Beach Corp
BTMD3.42-0.03
-0.87%
Biote Corp

POAI and

Correlation & Price change

A.I.dvisor tells us that POAI and IRIX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POAI and IRIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POAI
1D Price
Change %
POAI100%
+1.75%
IRIX - POAI
28%
Poorly correlated
+3.40%
NPCE - POAI
27%
Poorly correlated
+0.56%
NVTA - POAI
26%
Poorly correlated
+9.25%
TMDX - POAI
25%
Poorly correlated
-1.88%
LHDX - POAI
24%
Poorly correlated
+5.88%
More